Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection sufficient to allow satisfactory sexual activity.
It is very common and its prevalence increases with age, but it should not be considered simply a normal consequence of aging.
Erection requires adequate interaction between:
For this reason, a vascular, neurological, hormonal, anatomical, or psychological disorder can affect erectile function.
The initial evaluation is based mainly on:
The IIEF-5 questionnaire can be used to assess erectile function and quantify its severity.
Modifiable factors should be identified and treated first.
PDE5 inhibitors are usually the initial pharmacological treatment:
If there is no response or they are contraindicated, the following may be considered:
⚠️ Alert
PDE5 inhibitors must not be combined with nitrates because of the risk of severe hypotension.
Erectile dysfunction shares many risk factors with cardiovascular disease and can be an opportunity to detect undiagnosed vascular and metabolic factors.
Key concept
With a patient who has ED, we should not think only of "giving sildenafil". We have to investigate why they have erectile dysfunction.
Andrology does not study sexual function alone. It integrates erectile and ejaculatory function, reproduction, hormonal function, and diseases of the male genital tract.
Want us to let you know when this lesson is complete?
All set, we'll let you know! 🎉